ArticleAnnals of translational medicine2022

Crosstalk between the gut microbiome and clinical response in locally advanced thoracic esophageal squamous cell carcinoma during neoadjuvant camrelizumab and chemotherapy.

Liwei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.